PAHC News Alert Phibro Animal Health Corp (PAHC) 30.85 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phibro Animal Health Corp (PAHC) 30.85 $PAHC

Medtronic's Reveal Cardiac Monitor: Key to AF Detection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:15PM CST
The incremental cost-effectiveness ratio (ICER) associated with the utilization of Medtronic's (MDT) Reveal XT ICM came well within the cost-effectiveness range supported by the United Kingdom's National Institute of Clinical Excellence.
CSII: 35.69 (+0.17), MDT: 75.26 (+0.33), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65)

Phibro Animal Health: Market Expansion And New Contracts To Drive Earnings Growth
Ross Capital - at Seeking Alpha - Fri Feb 13, 10:35AM CST

PAHC: 30.85 (+0.36)

Phibro Animal Health (PAHC) in Focus: Stock Jumps 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:18AM CST
Phibro Animal Health Corporation (PAHC) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
ABAX: 60.93 (+0.65), PAHC: 30.85 (+0.36)

St. Jude Medical HALO US IDE Trial Tests 15mm Heart Valves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:13PM CST
Global medical devices company, St. Jude Medical (STJ), recently launched the HALO U.S. IDE Trial.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), STJ: 67.48 (+0.65)

ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:09PM CST
Through Jaysec's acquisition, ResMed (RMD) will experience reduced administrative burden owing to the self-serve software portal specifically designed for HME providers.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), RMD: 66.25 (+0.79)

Phibro Animal Health Corporation's (PAHC) CEO Jack Bendheim on Q2 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 7:48PM CST

PAHC: 30.85 (+0.36)

Phibro misses 2Q profit forecasts
Automated Insights - Tue Feb 10, 3:48PM CST
TEANECK, N.J. (AP) _ Phibro Animal Health Corp. (PAHC) on Tuesday reported fiscal second-quarter profit of $15.4 million.
PAHC: 30.85 (+0.36)

Phibro Animal misses by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:28PM CST

PAHC: 30.85 (+0.36)

Phibro Animal Health Corporation Reports Second Quarter
GlobeNewswire - Tue Feb 10, 3:08PM CST
Phibro Animal Health Corporation (Nasdaq AHC) today announced its financial results for its second quarter ended December 31, 2014.
PAHC: 30.85 (+0.36)

Phibro Animal declares $0.10 dividend
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 3:36PM CST

PAHC: 30.85 (+0.36)

Phibro Animal Health Corporation Declares Quarterly Dividend
GlobeNewswire - Mon Feb 09, 3:30PM CST
The Board of Directors of Phibro Animal Health Corporation (Nasdaq AHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on March 25, 2015, to stockholders of record at the close of business on March 4, 2015.
PAHC: 30.85 (+0.36)

Update: Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2014 Quarterly Financial Results
GlobeNewswire - Wed Feb 04, 4:15PM CST
Phibro Animal Health Corporation (Nasdaq AHC) will host a webcast and conference call to review second quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Tuesday, February 10, 2015.
PAHC: 30.85 (+0.36)

Cellular Dynamics International (ICEL) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:11AM CST
Cellular Dynamics International, Inc. (ICEL) was a big mover last session, as the company saw its shares rise over 8% on the day.
ICEL: 5.27 (+0.02), PAHC: 30.85 (+0.36)

Mead Johnson's US Expansion Drives Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:09AM CST
Mead Johnson (MJN) achieved positive sales growth in two of its three segments, while sales growth in Asia was not up to the mark owing to Mead Johnson's weak performance in China.
ICUI: 88.98 (+0.42), NXTM: 17.56 (-0.05), MJN: 101.89 (+2.32), PAHC: 30.85 (+0.36)

St. Jude Q4 Earnings Meet Estimates on Modest Sales Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 11:30AM CST
St. Jude Medical Inc (STJ) reported adjusted EPS of $1.03, which was in line with the Zacks Consensus Estimate.
ICUI: 88.98 (+0.42), NXTM: 17.56 (-0.05), PAHC: 30.85 (+0.36), STJ: 67.48 (+0.65)

Medtronic Completes Covidien Acquisition for $50B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 3:40PM CST
The combined company will now expedite Medtronic's (MDT) three fundamental strategies of therapy innovation, globalization and economic value.
ICUI: 88.98 (+0.42), MDT: 75.26 (+0.33), PAHC: 30.85 (+0.36), COV: 106.71 (-1.36)

Phibro Animal Health Corporation Announces Licensing Agreement With Merial for Phibro's Vaccine Delivery Technology
GlobeNewswire - Mon Jan 26, 3:30PM CST
Phibro Animal Health Corporation (Nasdaq AHC) today announced it has entered into a long-term global license arrangement with Merial SAS (Lyon, France) to share in the use of Phibro's vaccine delivery technology for use in animal vaccines. The agreement was signed in 2012 and is being announced today following Merial's receipt of marketing authorization in France for an avian vaccine product utilizing the licensed technology.
PAHC: 30.85 (+0.36)

Phibro Animal Health Corporation Announces Entry Into Collaboration Agreement, License Agreement and Intellectual Property Acquisition Agreement
GlobeNewswire - Thu Jan 22, 3:30PM CST
Phibro Animal Health Corporation ("Phibro" (Nasdaq AHC) today announced it has acquired exclusive North American distribution rights for vaccines using MJ Biologicals, Inc.'s ("MJB" vaccine technologies focused on the swine industry and additional vaccines that Phibro and MJB intend to develop, pursuant to a collaboration and distribution agreement. In addition, Phibro has acquired exclusive development and distribution rights outside North America for vaccine products using MJB technologies, pursuant to a technology license agreement.
PAHC: 30.85 (+0.36)

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2014 Quarterly Financial Results
GlobeNewswire - Wed Jan 07, 12:00PM CST
Phibro Animal Health Corporation (Nasdaq AHC) will host a webcast and conference call to review second quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Tuesday, February 10, 2015.
PAHC: 30.85 (+0.36)

Animal Feed Additives - Global Strategic Business Report
M2 - Tue Dec 16, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/24vhpg/animal_feed) has announced the addition of the "Animal Feed Additives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Animal Feed Additives in US$ Million by the following Product Segments: Antibiotics/Antibacterials, Vitamins, Antioxidants, Amino Acids, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 272 companies including many key and niche players such as: - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc. - Alltech Inc. - Archer Daniels Midland Company Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Product Definitions - Antibiotics/Antibacterials - Vitamins - Antioxidants - Amino Acids - Others II. EXECUTIVE SUMMARY 1. OUTLOOK 2. COMPETITIVE LANDSCAPE 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. REGULATORY & ENVIRONMENTAL ANALYSIS 6. PRODUCT INTRODUCTIONS/APPROVALS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc - Ajinomoto Eurolysine S.A.S - Alltech Inc - Archer Daniels Midland Company - BASF SE - Biovet JSC - Cargill, Inc - Provimi Holding - Chr. Hansen - DSM Nutritional - DuPont - Elanco Animal Health - Evonik Industries AG (Germany) - InVivo NSA S.A. (France) - Kemin Industries, Inc. (US) - Lonza Group Ltd (Switzerland) - Novozymes A/S (Denmark) - Novus International, Inc. (US) - Nutreco N.V (the Netherlands) - Phibro Animal Health Corporation (US) - Tessenderlo Group (Belgium) - The Mosaic Company (US) - Zoetis, Inc. (US) 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. MIDDLE EAST/AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/24...nimal_feed
ZTS: 45.46 (-0.33), ADM: 48.10 (+0.66), PAHC: 30.85 (+0.36)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 31

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 28

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
Gourmia Introduces Ceramic-Coated Air Fryer at Costco

Updated Category News Views 24

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 33

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Oracle Announces AI-Driven QuickStart Platform Launch

Updated Category News Views 32

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Continue Reading
Vayo Debuts as Booking Holdings Eyes $100M Investment

Updated Category News Views 16

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Continue Reading
Cogent Communications' Q3 2026 Earnings Call Details

Updated Category News Views 18

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 24

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 24

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 37

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Spotify's Recent Options Market Activity Insights

Updated Category News Views 125

Investor Sentiment and Options Market Trends for Spotify Technology Recent observations in the options market reveal that there is a noticeable bearish stance among significant investors concerning Spotify Technology (NYSE: SPOT). Understanding this shift can provide crucial insights for retail traders looking to navigate the complexities of the stock market. What This...

Continue Reading
Guide Outdoor Unveils ApexVision to Revolutionize Thermal Imaging

Updated Category News Views 136

Guide Outdoor Set to Showcase ApexVision at SHOT Show 2026 In an exciting revelation for outdoor enthusiasts and professionals, Guide outdoor will be showcasing its revolutionary ApexVision at the highly anticipated SHOT Show 2026 in Las Vegas. Taking place from January 20 to 23, this premier event for the shooting, hunting, and outdoor industry will serve as a platform...

Continue Reading
Waaree Solar Expands Horizons with Acquisition of Kotsons Ltd.

Updated Category News Views 110

Waaree Solar Enters Transformer Manufacturing Waaree Solar Americas is thrilled to announce a significant milestone with the strategic acquisition of 64% equity in Kotsons Private Limited by its parent company, Waaree Energies Limited. This acquisition transforms Kotsons into a subsidiary of Waaree Energies. The infusion of capital will enable an expansion of Kotsons'...

Continue Reading
Jefferies Updates Adani Green Energy's Price Target Amid Growth Plans

Updated Category News Views 240

Overview of Adani Green Energy's Current Position Recently, Jefferies has revised its outlook on Adani Green Energy, a notable player in the renewable energy sector, by reducing its price target to INR2,000, down from INR2,130. Despite this adjustment, Jefferies maintains a positive stance, continuing to endorse the stock with a Buy rating. Analysis of Quarterly...

Continue Reading
Uveitis Treatment Market Poised for Significant Growth by 2032

Updated Category News Views 137

Uveitis Treatment Market Overview The uveitis treatment market is on a remarkable growth trajectory, with projections indicating it will reach USD 4.69 billion by 2032. This surge is fueled by increased incidences of autoimmune and inflammatory ocular disorders. Notably, the market was valued at USD 2.26 billion in 2023, expanding at an impressive compound annual growth...

Continue Reading